Covid’s origin story mystery energizes the GOP — CMS reviewing Georgia’s Obamacare waiver — First in PULSE: Warren wants GIlead CEO to testify on drug prices

From: POLITICO Pulse - Friday Jun 04,2021 02:06 pm
Presented by AARP: Delivered daily by 10 a.m., Pulse examines the latest news in health care politics and policy.
Jun 04, 2021 View in browser
 
POLITICO's Pulse newsletter logo

By Adam Cancryn and Sarah Owermohle

Presented by

AARP

With Rachel Roubein, Alice Miranda Ollstein and Daniel Lippman

Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Care's morning newsletter, which is delivered to our s each morning at 6 a.m. The POLITICO Pro platform combines the news you need with tools you can use to take action on the day’s biggest stories. Act on the news with POLITICO Pro.

Quick Fix

Republicans are seizing on renewed interest in Covid-19's origins in China to push for a full investigation — and crank up scrutiny of President Joe Biden’s foreign policy.

Biden’s Medicare agency is re-evaluating Georgia's Trump-era plan to overhaul its Obamacare market.

Sen. Elizabeth Warren (D-Mass.) wants Gilead's CEO to testify as part of an examination of anti-competitive behavior in the drug industry.

WELCOME TO FRIDAY PULSE — where there's still no clear evidence that aliens are real, but also no evidence they're not not real. PULSE wants to believe; send tips of earthly or alien origin to acancryn@politico.com and sowermohle@politico.com.

A message from AARP:

Congress: It’s time to let Medicare negotiate for lower drug prices. The President, Congress, and the American people agree: we need to lower prescription drug prices. Americans can’t afford to pay the highest prices in the world for their prescription drugs. Giving Medicare the power to negotiate will save hundreds of billions of dollars and reduce prescription drug costs for all Americans. aarp.org/FairRxPrices

 
Driving the Day

COVID’s ORIGIN MYSTERY ENERGIZES THE GOP — Republicans are increasingly agitating for the creation of an independent commission or congressional probe into the genesis of the pandemic , amid fresh bipartisan interest in the possibility the coronavirus escaped from a Wuhan virology lab, POLITICO’s Melanie Zanona and Andrew Desiderio report.

Though some Republicans are already leading inquiries of their own, they’d need buy-in from the majority party to wield the subpoena power needed to get access to key documents and witnesses. The GOP is also prodding the White House over the issue, urging Biden in turn to pressure international organizations like the World Health Organization to help in the search for new information.

It’s this political angle that’s both energizing the party and threatening to divide it. Some Republicans searching for an effective attack on Biden have seized on the questions surrounding Covid-19’s origins, using them to hammer Biden for being soft on China.

“Everyone knows Biden and the Democrats will never stand up to China because they have too much invested there,” said Rep. Jim Banks of Indiana, chair of the conservative Republican Study Committee, vowing to “hold China accountable and make them pay” if Republicans win back the House in 2022.

Others have held off, believing they can still examine Covid on a bipartisan basis. Washington Rep. Cathy McMorris Rodgers, the top Republican on the Energy and Commerce Committee, declined to sign onto a recent letter demanding that Democrats open an investigation into Covid-19’s origin, in what some lawmakers saw as an effort to avoid politicizing the issue and jeopardizing possible bipartisan cooperation on her own probe into the virus.

There’s also division within the GOP over how aggressively to go after administration officials like Anthony Fauci, who voiced his belief early on that the virus jumped naturally from animals to humans. Fauci has since acknowledged there’s also a possibility its spread resulted from a lab accident.

Democrats, meanwhile, have remained noncommittal on the prospect of a wide-ranging review. But there are signs of restlessness: In recent weeks, the Senate has unanimously adopted measures calling on Biden to seek an international investigation and to declassify all the government’s information related to a potential coronavirus lab leak.

RODGERS SEEKS GAO ASSESSMENT ON COVID ORIGINSThe top E&C Republican and two other GOP committee members are asking the Government Accountability Office to assess whether there’s any available technology that could be used to determine the source of the virus, the discovery of which they believe will help to prevent future pandemics.”

The three Republicans — Rodgers and Reps. Morgan Griffith of Virginia and Brett Guthrie of Kentucky — also want the GAO to determine whether there are any policy options that could speed up development of such technology.

CMS STARTS REVIEWING GEORGIA’s OBAMACARE WAIVER — In one of her earliest actions since being confirmed, CMS chief Chiquita Brooks-LaSure sent a letter Thursday to Republican Gov. Brian Kemp seeking more analysis of Georgia’s plan to leave HealthCare.gov, POLITICO's Rachel Roubein reports.

In the letter, Brooks-LaSure cited executive actions aimed at bolstering Obamacare as a reason to conduct a new analysis of the waivers, as well as the temporary expansion of the law’s health insurance subsidies as part of March’s stimulus package.

Georgia will have a month to submit the new analysis of its waiver, which would opt the state out of a centralized website for Obamacare plans in 2023 in favor of letting agents, brokers and other private entities sell Affordable Care Act coverage, alongside skimpier options.

The Trump administration approved Georgia’s waiver last November, saying at the time it would give residents more choice in the individual market. Democrats have since argued that it violates Obamacare and would hamper access to coverage.

 

SUBSCRIBE TO "THE RECAST" TODAY: Power is shifting in Washington and in communities across the country. More people are demanding a seat at the table, insisting that politics is personal and not all policy is equitable. The Recast is a twice-weekly newsletter that explores the changing power dynamics in Washington and breaks down how race and identity are recasting politics and policy in America. Get fresh insights, scoops and dispatches on this crucial intersection from across the country and hear critical new voices that challenge business as usual. Don't miss out, SUBSCRIBE . Thank you to our sponsor, Intel.

 
 


On the Hill

FIRST IN PULSE: WARREN WANTS GILEAD CEO TO TESTIFY ON DRUG PRICES — Warren is inviting the drug company’s chief executive, Daniel O’Day, to a June 16 hearing on competition in the pharmaceutical industry, POLITICO’s Alice Miranda Ollstein reports.

In a letter to O’Day seeking his testimony, Warren wrote that her Senate Finance subcommittee on fiscal responsibility and economic growth is focusing on anti-competitive behavior that affects consumer access, innovation and pricing, and criticized Gilead for the “prohibitively high prices” of its hepatitis C and HIV/AIDS antiviral drugs.

“Gilead has taken some steps to expand access to these critical drugs. But the company is set to hold on to its monopoly over its hepatitis C medications using ‘thickets’ of questionable patents,” Warren wrote.

LAWMAKERS PRESS CMMI OVER TRANSPARENCY — Two dozen House lawmakers are pressuring CMS to share more details about the work of its Innovation Center, arguing that the decision-making around its sweeping demonstration projects is too opaque.

The bipartisan group in a letter to CMMI chief Liz Fowler criticized the center’s metrics for judging the success of its health initiatives, calling them “biased toward savings rather than improving beneficiary health or addressing health disparities.” It also contended that CMMI’s work could be improved with greater input from Congress and the broader public.

“The Department of Health and Human Services needs to reveal the modeling which produces estimates of savings and how quality will be affected,” the lawmakers, led by Reps. Terri Sewell (D-Ala.) and Adrian Smith (R-Neb.) wrote. “Stakeholders need to know what analytics and standards are used to define a successful demonstration.”

 

Advertisement Image

 
Around the World

WELLCOME TO U.K.: DONATE YOUR DOSES — The global health research charity is calling on the U.K. to send at least 20 percent of its vaccine doses to needy countries, warning that “failing to act now risks reversing our hard-won progress.”

“The world won’t be safe while any single country is still fighting the virus,” Wellcome Trust Director Jeremy Farrar and Steven Waugh, executive director for the United Kingdom Committee for UNICEF, wrote to Prime Minister Boris Johnson.

— The backdrop: The letter comes as the U.K. hosts the G-7’s health summit and amid intensifying pressure for vaccine-rich countries to share doses with the rest of the world. The U.S. on Thursday detailed long-awaited plans to distribute an initial 25 million doses abroad, with plans to eventually send 80 million total to other countries by the end of the month.

Names in the News

Don Crane, the president and CEO of America’s Physician Groups, will resign. Crane has led the organization representing physician groups for 21 years. He’ll remain at the helm until APG settles on a successor.

Saumitra Thakur is now a managing partner at MedMountain Ventures, a health care venture fund. He is also a full hospitalist physician in San Francisco.

A message from AARP:

Congress: Act now to lower prescription drug prices. Every year, Medicare spends more than $129 billion on prescription drugs. Yet, it's prohibited by law from using its buying power to negotiate with drug companies for lower prices. This must change. Americans are sick and tired of paying three times what people in other countries pay for the same medicine, forcing many to choose between buying the prescription drugs they need and paying for food and rent. aarp.org/FairRxPrices

 


What We're Reading

The CDC’s shift on indoor masking is driving anxiety among retail, hospitality and fast food workers who can no longer ask customers to cover their faces, The New York Times’ Noam Scheiber reports.

In an interview with Kaiser Health News’ Julie Rovner, Brooks-LaSure vowed to focus the agency’s policies and regulations on expanding health coverage.

Fauci told the Financial Times’ Kiran Stacey and Demetri Sevastopulo that China should release the medical records of the three researchers at the Wuhan Institute of Virology who fell ill weeks before Covid-19 began spreading.

 

SUBSCRIBE TO WEST WING PLAYBOOK: Add West Wing Playbook to keep up with the power players, latest policy developments and intriguing whispers percolating inside the West Wing and across the highest levels of the Cabinet. For buzzy nuggets and details you won't find anywhere else, subscribe today.

 
 
 

Follow us on Twitter

Joanne Kenen @joannekenen

Adriel Bettelheim @abettel

Jason Millman @jasonmillman

Lauren Morello @lmorello_dc

Sara Smith @sarasmarley

Adam Cancryn @adamcancryn

Tucker Doherty @tucker_doherty

Dan Goldberg @dancgoldberg

David Lim @davidalim

Susannah Luthi @SusannahLuthi

Alice Miranda Ollstein @aliceollstein

Sarah Owermohle @owermohle

Carmen Paun @carmenpaun

Rachel Roubein @rachel_roubein

Darius Tahir @dariustahir

Erin Banco @ErinBanco

Lauren Gardner @Gardner_LM

Katherine Ellen Foley @katherineefoley

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Pulse